Skip to main content
. 2021 Jun 2;14(11):3010. doi: 10.3390/ma14113010

Figure 7.

Figure 7

Evaluation of the interaction level of boron carbide nanoparticles with myeloid and cancer cells. Mean fluorescence intensity (MFI) was analyzed using flow cytometry after 4 and 24 h of exposure of RAW264.7 (A,B) and MC38/0 cells (C,D) on the labeled carrier. IgG, human immunoglobulin; IgG–FITC, fluorescein-labeled IgG; B4C, boron carbide nanoparticles; B4C Ig–FITC, boron carbide nanoparticles functionalized with human FITC-labeled IgG.